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Expected Results
Hypothesis 1: We will run a mixed-effect ANOVA with time as the within-subject
variable and treatment as the between-subjects variable. We expect a time x
treatment interaction. We expect that follow-up contrasts will show that those in the
ayahuasca condition will have lower levels of methamphetamine than those in the
control condition.
For Hypotheses 2-5 we will run a series of Hayes’ Process Models (Model 4) with
posttest methamphetamine concentration as the DV, treatment condition as the IV,
biochemical (H2), physiological (H3), psychological (H4), or transcendent (H5)
mechanisms as the mediator, and pretest methamphetamine concentration as a
control variable. In each case, we will use 5,000 percentile bootstrapped samples to
calculate the average standard error of the indirect effect.
Hypothesis 2: We expect that the indirect effect of the biochemical mechanisms will
be significant. Specifically, the lower average variability of dopamine in the limbic
system will explain the reduced concentration of methamphetamine at posttest
(controlling for pretest) among those in the ayahuasca condition.
Hypothesis 3: We expect that the indirect effect of the physiological mechanisms will
be significant. Specifically, the lower average concentration of dopamine in the
nucleus accumbens will explain the reduced concentration of methamphetamine at
posttest (controlling for pretest) among those in the ayahuasca condition.
Hypothesis 4: We expect that the indirect effect of the psychological mechanisms will
be significant. Specifically, the higher self-reported behavioral health will explain the
reduced concentration of methamphetamine at posttest (controlling for pretest)
among those in the ayahuasca condition.
Hypothesis 5: We expect that the indirect effect of the transcendent mechanisms will
be significant. Specifically, the higher self-transcendence will explain the reduced
concentration of methamphetamine at posttest (controlling for pretest) among those
in the ayahuasca condition.
Literature Review 
Biochemical: Ayahuasca’s anti-addictive properties are attributed to N,N-
dimethyltryptamine’s global impact on the neurotransmitters released by dopaminergic
and serotonergic neurons. N,N-dimethyltryptamine’s affinity with serotonin receptors
elicits agonism in the 5HT2A receptor, which releases GABA, inhibiting the release of
dopamine. Ayahuasca’s monoamine oxidase inhibitor prevents the remaining dopamine
reabsorbed by the pre-synaptic membrane from being eliminated. Ayahuasca stabilizes the
concentration of dopamine in the reward center of the brain, between elevated levels of
dopamine associated with addictive behavior and low levels of dopamine associated with
withdrawals.
Physiological: Ayahuasca’s anti-addictive properties are attributed to N,N-
dimethyltryptamine’s reduction of dopamine concentration in the nucleus accumbens.
Ayahuasca’s inhibitory interference on dopamine within the nucleus accumbens alters
genetic expression of D1 receptors, triggering the upregulation of these receptors. This
increase in D1 receptors elicits an increased efficacy of dopamine in the mesolimbic
system, which reduces the cravings and withdrawals associated with self-administration of
a euphoric substance.
Psychological: Ayahuasca enables the processing of significant conscious and
unconscious experiences promoting the resolutions of suppressed emotions and an
improvement in resiliency in a phenomenon known as ego death. Ayahuasca increases
thought and speed facilitation to new associations, which promotes reflection on personal
issues. The death of the ego provides a resolution to the three-horned dilemma between
the ego, id, and superego dissolving internal trauma in the unconscious that are
responsible for addiction. Substance abuse is a reparative attempt to cope with internal
conflict related to the psychodynamic theory. Ayahuasca therapy promotes an oceanic
feeling of connectedness to the universe, which can resolve psychodynamic issues
regarding the environment.
Transcendent: Ayahuasca facilitates peak experiences, which can change a person’s
beliefs, values, and worldview promoting connection to their environment. Social
preoccupation with individualism in our society often leads to social isolation, and
addiction is a disruption of social integration resulting in a lack of social connections.
Citations 
Stimulant use disorder presents an enormous epidemic in our society; further research on new treatment methods remains necessary.
Ayahuasca (an entheogenic medicinal plant extract distinguished by the serotonergic psychedelic N,N-dimethyltryptamine in combination with a
monoamine oxidase inhibitor) may potentially be such a treatment for stimulant use disorder. Four theories hypothesize the biochemical,
physiological, psychological, and transcendent mechanisms describing ayahuasca’s potential as a therapeutic treatment. To investigate
ayahuasca’s potential as a mechanism of treatment, we propose a placebo-controlled experimental design comprising of 50 participants who are
moderate daily consumers of methamphetamine. We expect that ayahuasca treatment will result in reduced substance use, explained by
biophysiological and psychotranscendent mechanisms. Specifically, we hypothesize that the ayahuasca condition’s participants will have a lower
concentration of methamphetamine in their bloodstream, which will be explained via a reduced average variability of dopamine, a reduced
concentration of dopamine in the mesolimbic pathway, an increase in behavioral health, and an increase in measures of self transcendence. If
the results of this experiment support our hypotheses, this research study would be evidence that ayahuasca is an effective mechanism of
treatment for stimulant use disorder. Adjustment of N,N-dimethyltryptamine's schedule is necessary for ayahuasca therapy to be a viable
treatment method. Future studies should consider ayahuasca’s efficacy in relation to various substance use disorders compared to conventional
pharmacological substance treatment methods. Finally, we propose that future research should test the relationship between ayahuasca
treatment and the demographic characteristics of the participants.
Sample 
• 50 moderate methamphetamine users (N = 50) who consume between (0.2 – 0.5) grams of methamphetamine per day will be
recruited for this study. Participants over the age of 21 will be recruited through local advertisements on the internet through
websites such as Craigslist’s, Facebook, and Bluelight.
• Applicants will be given a questionnaire to pre-screen their characteristics for attributes that are unacceptable to the study. The
questionnaire will consist of eight inclusion questions and seventeen filler questions; this is to reduce the applicants suspicion about
our methods.
Measures
Inclusion questions: 8 items developed for this study to identify participants who meet eligibility criteria; “Do you consume more than
(0.5) grams of methamphetamine per day?”
Dopamine variability: Participants will undergo two 72 hours PET scan sessions to determine the average variability of dopamine in the
limbic system (12 measurements of dopamine per session in which participants will view methamphetamine cues every other
measurement period and control cues every other session). PET measurements will be observed through competition between
endogenously released dopamine and raclopride a selective antagonist of dopamine receptors. A drop in signal would indicate a
increase of dopamine released by transport vesicle into the synaptic cleft. Variability will be operationalized as the standard deviation
of dopamine over the 24 sessions.
Mesolimbic pathway dopamine concentration: Participants will undergo two 72 hours PET scan sessions to determine the average
concentration of dopamine in the nucleus accumbens of the mesolimbic pathway (12 measurements of dopamine per session in which
participants will view methamphetamine cues prior to every other measurement period). PET measurements will be observed through
competition between endogenously released dopamine and raclopride a selective antagonist of dopamine receptors. Concentration
will be operationalized as the average value of dopamine concentration over the 24 sessions.
Psychological health: 20 items from Kopta and Lowry’s (2002) Behavioral Health Questionnaire-20; “How satisfied have you been with
your life?”
Self-transcendence: 15 items from Haugan, Rannestad, Garasen, Hammervold, and Espenes’ (2012) self-transcendence scale; “Being
involved with other people or in my community when possible.”
Concentration of methamphetamine: Laboratory blood analysis of methamphetamine levels in blood plasma.
Procedure
• We will use an independent group study using a pretest-posttest waitlist-control design with one experimental ayahuasca condition
and a placebo condition.
• Randomization using matched pairs will be used to distribute the 50 participants (N = 50) in to two groups of 25 (n = 25), one group
for each condition.
• Participants will undergo two ayahuasca treatment sessions, two PET scanning sessions, and respond to two self-report scales.
• The study will be conducted over four weeks, a pretest measurement of methamphetamine in the participants bloodstream will be
collected after participants are assigned to their group and a posttest will be conducted at the end of the four weeks.
• The ayahuasca sessions will consist of two separate ceremonies for the experimental condition, perform by two indigenous Shipibo
shamans. The tea will be distributed in three eight-ounce servings, to be consumed over the course of the 10-hour therapy.
• The placebo group will participate in an identical ceremony, performed by another shipibo shaman. However, the shaman will not
distribute ayahuasca to the placebo group. Instead, the shaman will distribute melatonin in the form of a tea as a placebo to the
group.
Implications 
• The implications of this theoretical research is to advocate for the potential benefits of ayahuasca therapy for patients suffering from 
stimulant use disorder. Ayahuasca's therapeutic potential is demonstrated by a reduction of methamphetamine use in the experimental 
participants. 
• Evidence of a reduction in the consumption of methamphetamine in the experimental condition group would imply the efficacy of
ayahuasca therapy on various substance use disorders. 
• Adjustment of N,N-dimethyltryptamine's schedule is necessary for ayahuasca therapy to be a viable treatment method. Schedule V 
chemicals are medicinal substances with a low potential for abuse. Ayahuasca's inhibitory effects on of dopaminergic neurons indicates its 
low potential for abuse. 
• Ayahuasca therapy can provide treatment for patients that are experiencing undesirable results from conventional methods. The addiction 
crisis in our society continues to escalate. To treat this epidemic efficiently, a liberal treatment perspective must be realized. 
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Expected Results
Placebo
Ayahuasca
Hypotheses
Hypothesis 1: Participants in the ayahuasca condition will have a lower
concentration of methamphetamine in their bloodstream at the end of the four-
week experiment compared to the participants in the placebo condition.
Hypothesis 2: The reduced concentration of methamphetamine among those in
the ayahuasca compared to the control condition will be explained via
biochemical mechanisms (i.e., lower average variability of dopamine in the limbic
system).
Hypothesis 3: The reduced concentration of methamphetamine among those in
the ayahuasca compared to the control condition will be explained via
physiological mechanisms (i.e., lower average concentration of dopamine in the
nucleus accumbens).
Hypothesis 4: The reduced concentration of methamphetamine among those in
the ayahuasca compared to the control condition will be explained via
psychological mechanisms (i.e., higher self-reported behavioral health).
Hypothesis 5: The reduced concentration of methamphetamine among those in
the ayahuasca compared to the control condition will be explained via
transcendent mechanisms (i.e., higher self-transcendence).
Conclusion
• Addiction should be treated as a health issue rather than a criminal issue. Appropriate methods to treat addiction disorders must consider 
behavioral issues that pertain to substances along with the physical issues. Effective treatment methods promote connections that inspire 
the dissolution of underlying issues of addicts. Noninterventional methods promote aspects that build relationships in the lives of addicted 
individuals. Treatments should discourage convictions and focus on rehabilitation. Criminal regulations elicit difficult community integration 
which ultimately promotes addiction.
• Humans are social creatures as described by the attachment theory; substance use disorders are a symptom of a disturbed social 
integration. Social disturbances can pertain to disruptions in connections with an individual's peers, environment, society, or even their own 
identity. Substances themselves are not the issue, the problem relies on the person's inability or unwillingness to process their own 
emotions. 
• Substance use disorders are a reparative attempt to process internal conflicts or external disparities. When experiencing a lack of social 
integration, individuals will often find other methods to fulfill their instinctual desire for attachment. Substance use is a method that many 
individuals use to cope with their experienced lack of social connections.
• The limbic system has profound influence over basic emotions and drives which elicit an individual’s resiliency to substance use disorders. 
The nucleus accumbens is a critical component of the limbic system’s mesolimbic pathway, its terminals are the site of action for almost 
every recreational drug which causes a manifold increase in dopamine levels. Dopamine regulates reward- motivated behavior which also 
elicits an individual’s resiliency to substance use disorders. Erratic levels of dopaminergic neurons are believed to be responsible for 
addiction. 
Future Directions 
• Methamphetamine abuse represents a wide variety of substance use disorders to indicate ayahuasca’s therapeutic potential. 
Methamphetamine was selected as the user’s drug of choice because of its powerful affinity with dopamine. Future studies shou ld research 
the efficacy of ayahuasca therapy with various substance use disorders. 
• Racism influences youth who are exposed to drugs in their communities. The lack of connection seen by the disrespect of acknowledgement 
about the beliefs of minorities in our community is spurred by institutional racism. This institutional racism has misinformed the public about 
the potential harms of drugs. This concept elicits our inappropriate response to drug use in our society.  Future studies should research the 
relationship between ayahuasca treatment and the participant’s race. 
• People experiencing poverty generally have fewer alternatives in their lives. The availability of drugs and the reduction of alternatives has a 
positive correlation with addiction. The self-administration of addictive substances can be eliminated with positive alternatives. Future 
studies should research the relationship between ayahuasca treatment and the participant’s available resources. 
• Finally, future studies should research the efficacy therapeutic treatments oriented to the biochemical, physiological, psychological and 
transcendent mechanisms of substance use disorders compared to conventional pharmacological treatment methods. 
Culture 
• Substance use disorders are a complicated intersection of social and psychological
dynamics. The major determinants of substance use disorders pertain to the
disturbance of social connections elicited by trauma and the environment.
• Many of the people who consume substances are rational and functional
members of our society. Racism and stereotypes have further degraded our
societies perspective about drugs. These concepts do not properly reflect the
reality of the substance use issue in our society.
• The Drug Enforcement Administration’s current prohibitional regulation is an
inappropriate suppression of human rights.
• People who suffer from substance use disorders are discouraged from obtaining
treatment as they are threatened by prosecution.
